WTB
PCRX icon

Washington Trust Bank’s Pacira BioSciences PCRX Stock Holding History

Washington Trust Bank’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50
Closed -$4K – 804
2015
Q1 		$4K Hold
50
– – ﹤0.01% 743
2014
Q4 		$4K Hold
50
– – ﹤0.01% 796
2014
Q3 		$5K Hold
50
– – ﹤0.01% 734
2014
Q2 		$5K Hold
50
– – ﹤0.01% 795
2014
Q1 		$3K Buy
+50
New +$3.4K ﹤0.01% 777

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Washington Trust Bank's PCRX Position: Q2 2015 in Review

Washington Trust Bank sold out of Pacira BioSciences (PCRX) in Q2 2015, closing a stake of 50 shares — an estimated $4K sold.

Washington Trust Bank first reported a position in PCRX in Q1 2014 and held it in 5 quarters. The position peaked at $5K in Q3 2014. 187 funds tracked by Wall St. Rank hold PCRX as of Q2 2015.

  • Washington Trust Bank reported no remaining Pacira BioSciences position as of Q2 2015 after selling out during the quarter.
  • Washington Trust Bank sold 50 Pacira BioSciences shares in Q2 2015, an estimated $4K.
  • Washington Trust Bank first reported a position in Pacira BioSciences in Q1 2014 and held it in 5 quarters.
  • Washington Trust Bank's Pacira BioSciences position peaked at $5K in Q3 2014.
  • 187 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2015.

Based on Washington Trust Bank's 13F filing for Q2 2015, filed 10 Jul 2015.